Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 4/2005

01-05-2005

Factors associated with time to availability for cases reported to population-based cancer registries⋆

Authors: Julie Smith-Gagen, Rosemary D. Cress, Christiana M. Drake, Martha C. Felter, James J. Beaumont

Published in: Cancer Causes & Control | Issue 4/2005

Login to get access
Metadata
Title
Factors associated with time to availability for cases reported to population-based cancer registries⋆
Authors
Julie Smith-Gagen
Rosemary D. Cress
Christiana M. Drake
Martha C. Felter
James J. Beaumont
Publication date
01-05-2005
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 4/2005
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-004-5030-0

Other articles of this Issue 4/2005

Cancer Causes & Control 4/2005 Go to the issue

OriginalPaper

A randomized trial to promote pharmacotherapy use and smoking cessation in a Medicaid population (United States)

OriginalPaper

Leisure-time physical activity and lung cancer: a meta-analysis

OriginalPaper

Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem

OriginalPaper

Socio-economic factors and breast cancer survival – a population-based cohort study (Sweden)

OriginalPaper

Tobacco use and non-Hodgkin lymphoma: results from a population-based case–control study in the San Francisco Bay Area, California

OriginalPaper

CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits